Clinical Trials on Hemianopia Homonymous in New Zealand
Total 23 results
-
University of RochesterRochester Institute of TechnologyRecruitingStroke, Ischemic | Stroke Hemorrhagic | Hemianopia, Homonymous | Visual Field Defect, Peripheral | Hemianopsia | Hemianopia | Quadrantanopia | Occipital Lobe Infarct | Hemianopsia, Homonymous | Vision Loss Partial | QuadrantanopsiaUnited States
-
University of RochesterNational Institutes of Health (NIH)RecruitingStroke, Ischemic | Stroke Hemorrhagic | Visual Field Defect, Peripheral | Hemianopsia | Hemianopia | Quadrantanopia | Homonymous Hemianopia | Occipital Lobe Infarct | Visual Fields Hemianopsia | Vision Loss Partial | Peripheral Visual Field Defect of Both Eyes | Peripheral Visual Field Defect | Homonymous Hemianopsia and other conditionsUnited States
-
University of RochesterNational Eye Institute (NEI)Active, not recruitingStroke, Ischemic | Hemianopia | Quadrantanopia | Vision Loss Partial | Hemianopia HomonymousUnited States
-
University of RochesterActive, not recruitingStroke, Ischemic | Hemianopia | Quadrantanopia | Cortical Blindness | Vision Loss Partial | Hemianopia Homonymous | Vision; Loss, Both Eyes | Stroke - Occipital InfarctionUnited States
-
University of RochesterEnvision Solutions, LLCCompletedHemianopia | Quadrantanopia | Stroke Induced Vision LossUnited States
-
AmgenCompletedHomozygous Familial HypercholesterolemiaNew Zealand, South Africa, France, United States, Spain, Belgium, Czechia, Italy, Netherlands, Hong Kong, Canada, Lebanon
-
Novartis PharmaceuticalsRecruitingHeterozygous or Homozygous Familial HypercholesterolemiaNetherlands, Israel, Hungary, Italy, Germany, Spain, United States, France, Norway, Russian Federation, South Africa, Turkey, United Kingdom, Canada, Switzerland, Brazil, Lebanon, Slovenia, Poland, Taiwan, Malaysia
-
The Rogosin InstituteRecruitingHomozygous Familial HypercholesterolemiaUnited States
-
Arrowhead PharmaceuticalsActive, not recruitingHomozygous Familial HypercholesterolemiaAustralia, Canada, United States, South Africa
-
AmgenCompletedHomozygous Familial Hypercholesterolemia HoFHIndia
-
Cerenis Therapeutics, SACompletedHomozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Netherlands, United Kingdom
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, Australia, Austria, Canada, France, Greece, Italy, Japan, South Africa, Ukraine
-
LIB Therapeutics LLCCompletedHomozygous Familial HypercholesterolemiaUnited States, Israel, Norway, South Africa, Turkey, India
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Australia, Austria, Netherlands, Taiwan, Ukraine
-
Regeneron PharmaceuticalsCompletedHomozygous Familial HypercholesterolemiaUnited States, Netherlands, South Africa, Australia, Austria, Canada, Czechia, France, Greece, Italy, Japan, Ukraine
-
AmgenCompletedFamilial HypercholesterolemiaCanada, Italy, Norway, Belgium, United States, Turkey, Australia, Austria, South Africa, Poland, Switzerland, Spain, Portugal, Slovenia, Brazil, Russian Federation, Hungary, United Kingdom, Colombia, Czechia, Netherlands, Greece, Ma...
-
Amryt PharmaRecruitingHomozygous Familial HypercholesterolemiaItaly, United States, Argentina, Canada, France, Greece, Netherlands, United Kingdom
-
Regeneron PharmaceuticalsSanofiCompletedHomozygous Familial HypercholesterolemiaUnited States, South Africa, Canada, Greece, Japan, Ukraine, Austria, Czechia, France, Germany, Italy, Taiwan, Turkey
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous or Heterozygous for the F508del-CFTR MutationUnited States, France, United Kingdom, Germany, Spain, Belgium, Canada, Australia, Netherlands, Denmark, Czech Republic, Italy, Austria, Ireland, Sweden
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous for the F508del CFTR MutationUnited States, France, Spain, Belgium, Canada, Austria, Australia, Germany, United Kingdom, Denmark
-
Vertex Pharmaceuticals IncorporatedCompletedCystic Fibrosis, Homozygous for the F508del CFTR MutationUnited States, Germany, Canada, Netherlands, Czech Republic, Italy, Ireland, Sweden, United Kingdom, Australia, France
-
Novartis PharmaceuticalsCompletedElevated Cholesterol | Homozygous Familial Hypercholesterolemia | Heterozygous Familial Hypercholesterolemia | ASCVDUnited States, Canada, Czechia, Denmark, Germany, Hungary, Netherlands, Poland, South Africa, Spain, Sweden, Ukraine, United Kingdom
-
Novartis PharmaceuticalsTerminatedc-MET Inhibitor; PI3K Inhibitor, PTEN Mutations, Homozygous Del. of PTEN or PTEN Neg. by IHC, c-Met Ampli. by FISH, INC280, BKM120, Buparlisib; Recurrent GBMSpain, Switzerland, Germany, United States, Netherlands